Investing Ideas
/
Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

2 new

Companies with a Value score of at least 3, ordered by Value score

33 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
TEVA Teva Pharmaceutical Industries	CHF 7.85	0%	0%	CHF 18.6b	CHF 10.69	PS1.1x	E65.8%	0%
SDZ Sandoz Group	CHF 42.26	-5.7%	50.8%	CHF 18.5b	CHF 44.64	PS2x	E29.5%	1.0%
MER Merck KGaA	CHF 128.22	-0.7%	n/a	CHF 59.2b	CHF 171.11	PE21.8x	E10.2%	1.6%
J7Z Jazz Pharmaceuticals	CHF 123.13	9.2%	n/a	CHF 8.2b	CHF 167.68	PE17.7x	E9.7%	n/a
NOVN Novartis	CHF 96.59	-1.2%	7.3%	CHF 189.9b	CHF 102.64	PE17.7x	E7.0%	3.6%
001102657 GSK	CHF 26.12	0%	-2.8%	CHF 70.6b	CHF 34.09	PE13.8x	E8.9%	5.7%
BMY Bristol-Myers Squibb	CHF 54.24	0%	0%	CHF 100.3b	CHF 58.46	PS2.2x	E49.0%	4.8%
BAYN Bayer	CHF 67.99	0%	-66.0%	CHF 19.3b	CHF 97.14	PS0.4x	E43.3%	0.6%
JCARE Joincare Pharmaceutical Group IndustryLtd	US$8.00	0%	0%	US$21.6b	US$9.61	PE14.7x	E12.5%	1.6%
COPN Cosmo Pharmaceuticals	CHF 66.90	5.0%	2.9%	CHF 1.1b	CHF 98.37	PE16.4x	E21.5%	2.8%
2HQ Tilray Brands	CHF 46.28	0%	0%	CHF 874.6m	CHF 90.47	PS1.1x	E76.7%	n/a
NOVNEE Novartis	CHF 96.72	-1.1%	7.2%	CHF 189.9b	CHF 102.78	PE17.7x	E7.0%	3.6%
010683053 Merck	CHF 76.61	-2.7%	-31.6%	CHF 210.7b	CHF 106.17	PE12.3x	E7.6%	3.9%
TECN Tecan Group	CHF 207.80	-0.9%	-41.3%	CHF 2.7b	CHF 283.83	PE26.3x	E13.9%	1.4%
1CG New CRISPR Therapeutics	CHF 48.02	33.0%	-28.8%	CHF 4.5b	CHF 76.88	PS120x	E47.8%	n/a
XLS Xlife Sciences	CHF 20.00	-1.5%	-57.3%	CHF 120.6m	n/a	PE5.4x	n/a	n/a
000935700 Gilead Sciences	CHF 68.48	0%	10.5%	CHF 94.1b	CHF 82.84	PE17.2x	E7.8%	4.0%
QIA Qiagen	CHF 50.36	0%	0%	CHF 9.2b	CHF 61.37	PE27x	E11.3%	n/a
GXI Gerresheimer	CHF 75.60	0%	0%	CHF 2.8b	CHF 97.17	PE24.5x	E16.6%	1.5%
RO Roche Holding	CHF 316.40	1.5%	28.7%	CHF 236.9b	CHF 331.89	PE28.3x	E14.6%	3.3%
ROG Roche Holding	CHF 294.70	1.0%	27.7%	CHF 236.9b	CHF 309.12	PE28.3x	E14.6%	3.3%
EVT Evotec	CHF 27.76	0%	0%	CHF 1.9b	CHF 29.26	PS2.4x	E74.2%	n/a
BIIB Biogen	CHF 222.00	0%	0%	CHF 27.0b	CHF 320.85	PE23.3x	E17.1%	n/a
000982352 AstraZeneca	CHF 135.45	1.1%	19.7%	CHF 182.8b	CHF 162.77	PE32.5x	E16.5%	2.1%

Page 1 of 2